MDspire News

Global hub for healthcare professionals with trusted clinical content, breaking news, and education to fuel your growth.

[MDspire News @MDspireNews]

💬 Can empathy be trained?

A study involving 303 healthcare professionals put simulation-based training to the test and found a significant increase in empathic attitudes after the program.

Explore the findings: https://t.co/USjuWjvRzX

#Healthcare #MedicalEducation #PatientCare

[MDspire News @MDspireNews]

🍺 Beer + HIIT? Researchers put the combination to the test.

The BEER-HIIT study asked whether moderate alcohol consumption affects heart rate variability adaptations after 10 weeks of high-intensity training.

👀 See what they found: https://t.co/jcvV26A0td

#Cardiology #HIIT

[MDspire News @MDspireNews]

Have you registered?

The future of healthcare is being shaped by artificial intelligence.

From predictive analytics and precision medicine to clinical decision support and workflow automation, the Cleveland Clinic AI Summit for Healthcare Professionals will showcase how AI is transforming patient care across specialties.

Conexiant is proud to be the exclusive media partner, bringing you expert interviews and insights and specialty-specific coverage from one of healthcare's premier AI education events.

Whether you attend in person or via livestream, now is the time to join the conversation.

📅 August 28, 2026
📍 Attend in Cleveland or via livestream

Register today: https://t.co/fM2TDdm5HE

[MDspire News @MDspireNews]

🔬 A new view on complex skull base surgery?

Initial experience using the ORBEYE™ 4K 3D exoscope for the combined petrosal approach in petroclival meningiomas showed encouraging visualization and early outcomes.

🔗 Read more: https://t.co/m8xzF1TenA

#Neurosurgery

[MDspire News @MDspireNews]

Join healthcare leaders at Cleveland Clinic's AI Summit for Healthcare Professionals to explore the latest innovations in AI, from diagnostics and precision medicine to education, operations, and patient engagement.

As the exclusive media partner, Conexiant will bring you the conversations that matter most, with interviews, expert commentary, and specialty-specific reporting you won't find anywhere else.

📅 August 28, 2026
📍 Cleveland, OH + Livestream

🔗 Reserve your spot: https://t.co/fM2TDdm5HE

[MDspire News @MDspireNews]

🧪 A new screening platform could broaden molecular glue discovery.

Researchers identified a glutathionylation-activated molecular glue that recruits DCAF11 to degrade DDX18, revealing a new mechanism of targeted protein degradation.

🔗 https://t.co/YWRnXEeE5v

#DrugDiscovery

[MDspire News @MDspireNews]

🎯 Could AI speed up breast cancer treatment planning?

Calvin Chao of Artera discusses an FDA-cleared digital pathology tool that can provide risk stratification for early-stage HR+/HER2− breast cancer in about an hour.

🔗 https://t.co/yTLPK8huw0

#BreastCancer #DigitalPathology

[MDspire News @MDspireNews]

We're proud to serve as the exclusive media partner of Cleveland Clinic's AI Summit for Healthcare Professionals.

Artificial intelligence is transforming every aspect of healthcare—from clinical decision support and workflow optimization to patient engagement, medical education, and research.

📅 August 28, 2026
📍 Cleveland, OH + Livestream

🔗 Register today: https://t.co/fM2TDdm5HE

[MDspire News @MDspireNews]

👃 Does smell loss tell us more than we think?

A new meta-analysis involving more than 187,000 patients explored the relationship between olfactory impairment and depression, uncovering some surprising differences depending on how smell loss is measured.

Could patient-reported symptoms reveal something objective tests miss?

Read the findings 🔗 https://t.co/yqb7qLg6ED

#MentalHealth #Depression #MDSpireNews

[MDspire News @MDspireNews]

Could adjuvant ensartinib change the treatment landscape for resected ALK-positive #NSCLC?

New phase 3 ELEVATE trial results published in NEJM highlight improved disease-free survival after surgery.

🔗 https://t.co/I8eMvnLg7R

#LungCancer #Oncology

[MDspire News @MDspireNews]

A new name. The same trusted partner.

Today, Conexiant News officially becomes MDSpire News.

While the name is changing, our trusted editorial team, clinical audiences, and partnership opportunities remain the same.

Learn more: https://t.co/jHSEP4bC0m
#MDSpireNews

[MDspire News @MDspireNews]

High procalcitonin after 7 days of antibiotics... should treatment continue?

A new BALANCE trial analysis found no evidence that extending therapy from 7 to 14 days improved outcomes in this subgroup.

Read more: https://t.co/Iv0IYDRwII

[Kaishauna Guidry, MD, HMDC @DrMamaKai]

Nicotine Pods Tied to More Abstinence https://t.co/C5ILa6YbUQ @conexiant

[MDspire News @MDspireNews]

"Natural" doesn't always mean safe.

A tragic new case report describes a 7-year-old who developed fatal acute liver failure after taking an herbal remedy for jaundice that was found to contain arsenic and lead.

Read more: https://t.co/d3tCjFUIBu

#MedTwitter #PatientSafety #Toxicology

[MDspire News @MDspireNews]

Could GLP-1 receptor agonists improve rotator cuff repair outcomes?

A new study found preoperative GLP-1 use was linked to fewer revisions in patients with obesity, without increasing short-term complications.

Read more: https://t.co/qBvcmyV8wN

#Orthopedics #GLP1

[MDspire News @MDspireNews]

👁️ Where are patients being lost in the diabetic retinopathy care pathway?

A US systematic review identified major gaps in screening, diagnosis awareness, referral, and follow-up, with more than half of patients unaware they had diabetic retinopathy despite clinical evidence of disease.

Read more: https://t.co/Q9A75sKtdC

[MDspire News @MDspireNews]

🤖 Can AI help speed up urine drug test interpretation?

A new study found an AI-assisted workflow maintained high interpretive accuracy while reducing laboratory sign-out time by up to 51% in a supervised clinical setting.

Read more: https://t.co/sNNPyOnsyi

#LaboratoryMed

[MDspire News @MDspireNews]

FDA expands approval of CASGEVY. The CRISPR/Cas9 gene-edited therapy is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

Read more: https://t.co/Q1PLFIWIEZ

#GeneTherapy #CRISPR #Hematology

[BIDMC Smith Center @SmithBIDMC]

What is the future of echocardiography? AI, big data and the sonographer workforce. @DocStrom discusses with @conexiant at the @ASE360's 37th Scientific Sessions.
🔗 https://t.co/piHWrg7N37
@BidmcCvi

[MDspire News @MDspireNews]

We’re on-site at #ASE2026, where Evan Unger, MD, FACR, presented late-breaking findings on MVT-100, a novel perflutren-based ultrasound-enhancing agent.

In an early-phase study, MVT-100 showed higher LV opacification scores and reduced acoustic shadowing vs Definity, with no serious adverse events reported.

@ASE360 #echocardiography

https://t.co/8yRH0uVTjV